AR025763A1 - Metodos y sistemas para el tratamiento del tejido enfermo con composiciones antiinfecciosas - Google Patents

Metodos y sistemas para el tratamiento del tejido enfermo con composiciones antiinfecciosas

Info

Publication number
AR025763A1
AR025763A1 ARP000105002A ARP000105002A AR025763A1 AR 025763 A1 AR025763 A1 AR 025763A1 AR P000105002 A ARP000105002 A AR P000105002A AR P000105002 A ARP000105002 A AR P000105002A AR 025763 A1 AR025763 A1 AR 025763A1
Authority
AR
Argentina
Prior art keywords
treatment
systems
methods
infective
diseased epithelial
Prior art date
Application number
ARP000105002A
Other languages
English (en)
Spanish (es)
Original Assignee
B Ron Johnson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by B Ron Johnson filed Critical B Ron Johnson
Publication of AR025763A1 publication Critical patent/AR025763A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A61K31/055—Phenols the aromatic ring being substituted by halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4425—Pyridinium derivatives, e.g. pralidoxime, pyridostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M35/00—Devices for applying media, e.g. remedies, on the human body
    • A61M35/003—Portable hand-held applicators having means for dispensing or spreading integral media
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M35/00—Devices for applying media, e.g. remedies, on the human body
    • A61M35/003—Portable hand-held applicators having means for dispensing or spreading integral media
    • A61M35/006—Portable hand-held applicators having means for dispensing or spreading integral media using sponges, foams, absorbent pads or swabs as spreading means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
ARP000105002A 1999-09-22 2000-09-22 Metodos y sistemas para el tratamiento del tejido enfermo con composiciones antiinfecciosas AR025763A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/401,076 US6211243B1 (en) 1999-09-22 1999-09-22 Methods for treating cold sores with anti-infective compositions

Publications (1)

Publication Number Publication Date
AR025763A1 true AR025763A1 (es) 2002-12-11

Family

ID=23586190

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000105002A AR025763A1 (es) 1999-09-22 2000-09-22 Metodos y sistemas para el tratamiento del tejido enfermo con composiciones antiinfecciosas

Country Status (13)

Country Link
US (5) US6211243B1 (enExample)
EP (2) EP1404174B1 (enExample)
JP (2) JP5215514B2 (enExample)
AR (1) AR025763A1 (enExample)
AT (2) ATE491436T1 (enExample)
AU (3) AU777656B2 (enExample)
BR (2) BR0014205B1 (enExample)
CA (2) CA2384829A1 (enExample)
DE (3) DE60045394D1 (enExample)
GB (2) GB2370773B (enExample)
MX (2) MXPA02002975A (enExample)
PE (1) PE20010709A1 (enExample)
WO (3) WO2001020981A2 (enExample)

Families Citing this family (100)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7846919B2 (en) * 1998-02-10 2010-12-07 Dermex Pharmaceuticals, Llc Chelated 8-hydroxyquinoline and use thereof in a method of treating epithelial lesions
US6224579B1 (en) * 1999-03-31 2001-05-01 The Trustees Of Columbia University In The City Of New York Triclosan and silver compound containing medical devices
US6641591B1 (en) 1999-08-26 2003-11-04 John H. Shadduck Instruments and techniques for controlled removal of epidermal layers
US6759434B2 (en) 1999-09-22 2004-07-06 B. Ron Johnson Anti-infective compositions, methods and systems for treating disordered tissue
US8173709B2 (en) * 1999-09-22 2012-05-08 Quadex Pharmaceuticals, Llc Anti-infective methods for treating pathogen-induced disordered tissues
US6211243B1 (en) * 1999-09-22 2001-04-03 B. Ron Johnson Methods for treating cold sores with anti-infective compositions
US6835184B1 (en) * 1999-09-24 2004-12-28 Becton, Dickinson And Company Method and device for abrading skin
US7329412B2 (en) * 2000-12-22 2008-02-12 The Trustees Of Columbia University In The City Of New York Antimicrobial medical devices containing chlorhexidine free base and salt
US6846846B2 (en) * 2001-10-23 2005-01-25 The Trustees Of Columbia University In The City Of New York Gentle-acting skin disinfectants
US20030143264A1 (en) * 2002-01-30 2003-07-31 Vincent Margiotta Topical anesthetic-antiseptic patch
EP1480517A4 (en) * 2002-02-07 2007-08-22 Univ Columbia ZINC SALT COMPOSITIONS FOR PREVENTING MOLECULAR BREAST EXTRACTION THROUGH SPERMICIDES AND MICROBICIDES
US7879365B2 (en) * 2002-02-07 2011-02-01 The Trustees Of Columbia University In The City Of New York Zinc salt compositions for the prevention of dermal and mucosal irritation
US7745425B2 (en) * 2002-02-07 2010-06-29 The Trustees Of Columbia University In The City Of New York Non-irritating compositions containing zinc salts
US20030224474A1 (en) * 2002-05-30 2003-12-04 Litman Mark A. Rapid-acting drug analysis system
US7261701B2 (en) * 2002-10-03 2007-08-28 3M Innovative Properties Co. Skin antiseptic composition dispenser and methods of use
US8105306B2 (en) * 2002-10-03 2012-01-31 3M Innovative Properties Company Skin antiseptic composition dispenser and methods of use
US20040204489A1 (en) * 2003-04-14 2004-10-14 Arthur Vanmoor Method of treating a swollen gland curing cancer
US20040208908A1 (en) * 2003-04-16 2004-10-21 The Trustees Of Columbia University In The City Of New York Antimicrobial medical articles containing a synergistic combination of anti-infective compounds and octoxyglycerin
JP2007534620A (ja) * 2003-07-17 2007-11-29 ザ トラスティース オブ コロンビア ユニバーシティ イン ザ シティ オブ ニューヨーク 第４級アンモニウム化合物と精油および／またはその構成要素の相乗的組合せを含む抗菌組成物
US20050019422A1 (en) * 2003-07-23 2005-01-27 Allergan, Inc. Method and composition for treating acne
CN1867251A (zh) * 2003-09-09 2006-11-22 3M创新有限公司 抗菌组合物和方法
CA2538119C (en) * 2003-09-09 2013-05-14 3M Innovative Properties Company Concentrated antimicrobial compositions and methods
US20050058673A1 (en) * 2003-09-09 2005-03-17 3M Innovative Properties Company Antimicrobial compositions and methods
MXPA06002917A (es) * 2003-09-15 2006-05-31 Schering Corp Sintesis de quinolina 5-carboxamidas utiles para la preparacion de inhibidores de fosfodiesterasa iv.
US20070218115A1 (en) * 2003-10-27 2007-09-20 Bott Richard R Preparation for Topical Application and Methods of Delivering an Active Agent to a Substrate
CA2543940A1 (en) * 2003-10-27 2005-05-19 Dow Corning Corporation Preparations for topical application and methods of delivering an active agent to a substrate
US20050100601A1 (en) * 2003-11-07 2005-05-12 Viratox, L.L.C. Virucidal activities of cetylpyridinium chloride
US20090232748A1 (en) * 2003-11-07 2009-09-17 Viratox, L.L.C. Virucidal activities of cetylpyridinium chloride
US20050154343A1 (en) * 2004-01-14 2005-07-14 Mohinder Singh Soft tip applicator for relieving mouth pain
US7316665B2 (en) * 2004-08-25 2008-01-08 Becton, Dickinson And Company Method and device for the delivery of a substance including a covering
US8198326B2 (en) * 2004-09-07 2012-06-12 3M Innovative Properties Company Phenolic antiseptic compositions and methods of use
US9028852B2 (en) * 2004-09-07 2015-05-12 3M Innovative Properties Company Cationic antiseptic compositions and methods of use
US20060051384A1 (en) * 2004-09-07 2006-03-09 3M Innovative Properties Company Antiseptic compositions and methods of use
US20060121098A1 (en) * 2004-11-15 2006-06-08 Mendoza Randall P Dermal defense system and method of use
US20050111900A1 (en) * 2004-11-30 2005-05-26 Francesca Fazzolari Ampoule and method of use
US20060173514A1 (en) * 2005-02-02 2006-08-03 Advanced Photodynamic Technologies, Inc. Wound treatment device for photodynamic therapy and method of using same
US8529560B2 (en) 2005-03-04 2013-09-10 The Invention Science Fund I, Llc Hair treatment system
US8540701B2 (en) * 2005-03-04 2013-09-24 The Invention Science Fund I, Llc Hair treatment system
US20060200114A1 (en) * 2005-03-04 2006-09-07 Searete Llc, A Limited Liability Corporation Of State Of Delaware Hair removal system with light source array
US8679101B2 (en) * 2005-03-04 2014-03-25 The Invention Science Fund I, Llc Method and system for temporary hair removal
US20060276859A1 (en) * 2005-06-02 2006-12-07 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Photopatterning of skin
US8157807B2 (en) 2005-06-02 2012-04-17 The Invention Science Fund I, Llc Skin treatment including patterned light
US8476319B2 (en) * 2005-03-10 2013-07-02 3M Innovative Properties Company Methods of treating ear infections
BRPI0608691A2 (pt) * 2005-03-10 2010-12-07 3M Innovative Properties Company composição antimicrobiana, e, métodos para matar ou inativar microorganismos em tecido da mucosa de um mamìfero, para tratar uma lesão ou ferimento infectado, para descolonização de microorganismos, para proporcionar eficácia antimicrobiana residual sobre uma superfìcie e para tratar uma condição
US20060229364A1 (en) * 2005-03-10 2006-10-12 3M Innovative Properties Company Antiviral compositions and methods of use
EP1868686A2 (en) * 2005-03-10 2007-12-26 3M Innovative Properties Company Antimicrobial pet wipes
CA2599653A1 (en) * 2005-03-10 2006-09-21 3M Innovative Properties Company Methods of reducing microbial contamination
US20070032846A1 (en) * 2005-08-05 2007-02-08 Bran Ferren Holographic tattoo
US9055958B2 (en) * 2005-06-29 2015-06-16 The Invention Science Fund I, Llc Hair modification using converging light
US20070038270A1 (en) * 2005-07-05 2007-02-15 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Multi step photopatterning of skin
US20070048340A1 (en) * 2005-08-31 2007-03-01 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Multi step patterning of a skin surface
US20070166402A1 (en) * 2005-12-12 2007-07-19 Friedlaender Mitchell H Compositions, methods and kits for removing debris from an ocular area
US20070147946A1 (en) * 2005-12-23 2007-06-28 3M Innovative Properties Cornpany Surgical prep solution applicator
US8048089B2 (en) 2005-12-30 2011-11-01 Edge Systems Corporation Apparatus and methods for treating the skin
US7759327B2 (en) * 2006-01-06 2010-07-20 The Trustees Of Columbia University In The City Of New York Compositions containing zinc salts for coating medical articles
US10172644B2 (en) 2006-03-29 2019-01-08 Edge Systems Llc Devices, systems and methods for treating the skin
US9566088B2 (en) 2006-03-29 2017-02-14 Edge Systems Llc Devices, systems and methods for treating the skin
US7662177B2 (en) 2006-04-12 2010-02-16 Bacoustics, Llc Apparatus and methods for pain relief using ultrasound waves in combination with cryogenic energy
US20080075793A1 (en) * 2006-09-21 2008-03-27 Dunshee Wayne K Antiviral compositions and methods of use
US7785026B2 (en) 2007-01-08 2010-08-31 Serena Eng Cosmetic applicator device
US8741954B2 (en) * 2007-02-21 2014-06-03 Viratox, L.L.C. Synergistic enhancement of calcium propionate
US9981069B2 (en) 2007-06-20 2018-05-29 The Trustees Of Columbia University In The City Of New York Bio-film resistant surfaces
EP2240031B1 (en) * 2007-12-31 2013-09-18 3M Innovative Properties Company Antimicrobial compositions
JP5508285B2 (ja) 2008-01-04 2014-05-28 エッジ システムズ コーポレーション 皮膚を治療するための装置および方法
US8814836B2 (en) 2008-01-29 2014-08-26 Edge Systems Llc Devices, systems and methods for treating the skin using time-release substances
WO2009097451A1 (en) 2008-01-29 2009-08-06 Edge Systems Corporation Apparatus and method for treating the skin
RU2519385C2 (ru) * 2008-05-26 2014-06-10 Новартис Аг Набор для местного нанесения лекарственных средств
KR100950004B1 (ko) * 2008-07-10 2010-03-31 수 경 최 구강염 치료용 스틱
US20100086625A1 (en) * 2008-10-08 2010-04-08 Abukurah Abdul R Methods for treating skin lesions
US20100094249A1 (en) * 2008-10-09 2010-04-15 Ty Caswell Wound treatment apparatus and methods
US20100316716A1 (en) * 2009-06-11 2010-12-16 Abukurah Abdul R Method for treating herpes zoster lesions
EP2263796B1 (de) * 2009-06-20 2018-07-25 Roche Diabetes Care GmbH Behälter mit Referenzlösung
US20110045103A1 (en) * 2009-08-19 2011-02-24 Abukurah Abdul R Methods for treating aids
WO2011057363A1 (en) * 2009-11-16 2011-05-19 Dynamiclear Pty Ltd Disposable device and uses thereof for skin and mucosal applications
US8846725B2 (en) 2011-01-24 2014-09-30 Quadex Pharmaceuticals, Llc Highly penetrating compositions and methods for treating pathogen-induced disordered tissues
US20120225143A1 (en) * 2011-03-03 2012-09-06 Ranir, Llc Cold sore formulation and related method of manufacture
WO2012152612A1 (en) * 2011-05-06 2012-11-15 Bayer Consumer Care Ag Stick pack with applicator
JP6609183B2 (ja) * 2012-09-19 2019-11-20 イノベイティブ ファーマシューティカル コンセプツ（アイピーシー）インコーポレイテッド 医療用塗布器
US9463180B2 (en) 2013-03-14 2016-10-11 Quadex Pharmaceuticals, Llc Treatment of molluscum contagiosum
US9549930B2 (en) 2013-03-14 2017-01-24 Quadex Pharmaceuticals, Llc Combined systemic and topical treatment of disordered and/or prodromal stage tissue
US9125911B2 (en) * 2013-03-14 2015-09-08 Quadex Pharmaceuticals, Llc Combined systemic and topical treatment of disordered tissues
US10238812B2 (en) 2013-03-15 2019-03-26 Edge Systems Llc Skin treatment systems and methods using needles
ES2936988T3 (es) 2013-03-15 2023-03-23 Hydrafacial Llc Dispositivos y sistemas para el tratamiento de la piel
US10183039B2 (en) 2013-07-15 2019-01-22 Vanderbilt University Methods for the production of collagen IV
EP3237021B1 (en) * 2014-12-22 2020-12-23 Flexible Medical Packaging Ltd. Sanitising device
EP3237055B1 (en) 2014-12-23 2020-08-12 Edge Systems LLC Devices and methods for treating the skin using a rollerball or a wicking member
US10179229B2 (en) 2014-12-23 2019-01-15 Edge Systems Llc Devices and methods for treating the skin using a porous member
EP4197517A1 (en) 2015-07-08 2023-06-21 HydraFacial LLC Devices, systems and methods for promoting hair growth
CN105494343A (zh) * 2015-12-21 2016-04-20 常州市精尔锐工具制造有限公司 一种新型杀菌剂组合物
EP3755368A4 (en) 2018-02-23 2021-12-22 The Administrators of The Tulane Educational Fund PHARMACEUTICAL COMPOSITION FOR VIRUS INFECTIONS
US10369396B1 (en) * 2018-11-09 2019-08-06 Battelle Memorial Institute Assembly for decontaminating and method of manufacturing the assembly
US20220079319A1 (en) * 2018-12-19 2022-03-17 Glaxosmithkline Consumer Healthcare Holdings (Us) Llc Variable dose applicator
US11919672B2 (en) 2019-04-12 2024-03-05 Avery Dennison Corporation Apparatus and methods for fastening an element to a support structure
USD935875S1 (en) 2019-11-25 2021-11-16 Avery Dennison Corporation Fastener
USD936467S1 (en) 2019-11-25 2021-11-23 Avery Dennison Corporation Fastener set
US11291474B2 (en) 2020-01-06 2022-04-05 Ed F. Nicolas Skin treatment tool applicator tip
USD1016615S1 (en) 2021-09-10 2024-03-05 Hydrafacial Llc Container for a skin treatment device
USD1065551S1 (en) 2021-09-10 2025-03-04 Hydrafacial Llc Skin treatment device
USD1042807S1 (en) 2021-10-11 2024-09-17 Hydrafacial Llc Skin treatment tip
USD1084369S1 (en) 2023-02-10 2025-07-15 Hydrafacial Llc Skin treatment tip

Family Cites Families (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1519693A (en) 1924-03-05 1924-12-16 Fred R Moore Rotary medicine applicator
US1822566A (en) 1928-11-02 1931-09-08 Mine Safety Appliances Co Medicament applicator
US3369543A (en) 1965-03-30 1968-02-20 Deron Inc Medicinal applicators
US3614245A (en) 1967-08-15 1971-10-19 Gilbert Schwartzman Single-use applicator
JPS5038393A (enExample) 1973-08-10 1975-04-09
US4183684A (en) 1977-11-29 1980-01-15 Marion Health & Safety, Inc. Fluid dispensing unit
US4176197A (en) * 1978-02-03 1979-11-27 Dominion Pharmacal, Inc. Method for treating acne vulgaris
US4390539A (en) * 1979-04-13 1983-06-28 George F. And Irene Sherrill 1978 Trust No. 1 Method for the treatment of viral skin diseases
US4262007A (en) * 1979-04-13 1981-04-14 George F. Sherrill Method for the treatment of viral skin diseases
US4394381A (en) 1979-04-13 1983-07-19 George F. And Irene Sherrill 1978 Trust No. 1 Method for the relief of pain
US4486450B1 (en) 1980-07-14 1998-07-28 Joel E Bernstein Method of treating psoriatic skin and composition
US4975217A (en) 1981-07-20 1990-12-04 Kimberly-Clark Corporation Virucidal composition, the method of use and the product therefor
US4507281A (en) 1981-10-13 1985-03-26 Exovir, Inc. Interferon-containing compositions
US4957734A (en) 1982-06-14 1990-09-18 Exovir, Inc. Treatment of certain skin malignancies and pre-malignant skin lesions, herpes zoster and psoriasis
US4661354A (en) 1984-06-21 1987-04-28 Finnerty Edmund F Topical treatment of herpes simplex with a zinc sulfate-camphor water solution
US4797420A (en) * 1984-08-14 1989-01-10 Jabco Manufacturing, Inc. Disinfectant formulation and method of use
JPS6176401A (ja) * 1984-09-19 1986-04-18 Takeda Chem Ind Ltd 殺菌消毒剤および殺菌消毒法
EP0175338A3 (en) 1984-09-19 1988-06-01 Takeda Chemical Industries, Ltd. Disinfectants and antiseptics
GB8427770D0 (en) 1984-11-02 1984-12-12 Bio Medical Services Ltd Applying drug solution
US4828542A (en) 1986-08-29 1989-05-09 Twin Rivers Engineering Foam substrate and micropackaged active ingredient particle composite dispensing materials
EP0190797A3 (en) 1985-02-08 1987-05-20 John Kenneth Voit Method for killing viruses and composition therefor
US4895727A (en) 1985-05-03 1990-01-23 Chemex Pharmaceuticals, Inc. Pharmaceutical vehicles for exhancing penetration and retention in the skin
US4822605A (en) 1986-02-18 1989-04-18 Exovir, Inc. Compositions and methods employing the same for the treatment of viral and cancerous skin lesions and the like
US5458889A (en) 1986-05-22 1995-10-17 Atlantic Pharmaceutical Products Limited Methods and compositions for inhibiting or destroying viruses or retroviruses
US4929442A (en) 1986-09-26 1990-05-29 Exovir, Inc. Compositions suitable for human topical application including a growth factor and/or related materials
JPS6388861U (enExample) * 1986-11-27 1988-06-09
US5712257A (en) 1987-08-12 1998-01-27 Hem Research, Inc. Topically active compositions of mismatched dsRNAs
CA1273576A (en) 1987-09-16 1990-09-04 Patrick A. Beauchamp Topical treatment for diseased skin disorders
US4875602A (en) 1988-06-15 1989-10-24 Triad Direct Incorporated Self-contained liquid dispensing device
US4887994A (en) 1988-07-06 1989-12-19 Bedford Peter H Applicator swabs and method of making same
NO178843C (no) 1988-07-11 1996-06-19 Sspl Sa Safe Sex Prod Licens Fremgangsmåte for fremstilling av et farmasöytisk preparat for å forhindre seksuelt overförbare sykdommer
US4952204A (en) * 1988-08-10 1990-08-28 Gam-Med Packaging Corporation Dry handle swab assembly and unit
US5405602A (en) 1989-01-31 1995-04-11 Simmons; Paul L. Nonaqueous cold sterilant
US5637307A (en) 1989-01-31 1997-06-10 Simmons; Paul L. Method of immersion sterilization and organic cold chemical sterilant
US5016651A (en) 1989-08-29 1991-05-21 Stalcup Robert W Method of providing topoical anesthetic in a sanitary and convenient manner
US5036095A (en) 1989-11-14 1991-07-30 Guy Andermann Therapeutic use of DMDM Hydantoin
US5137724A (en) 1990-05-23 1992-08-11 Stichting Rega Vzw Combinations of TS-inhibitors and viral TK-inhibitors in antiherpetic medicines
GB9015910D0 (en) 1990-07-19 1990-09-05 Univ Bruxelles Novel use
US6355684B1 (en) 1990-10-11 2002-03-12 Meryl J. Squires Antimicrobial treatment for herpes simplex virus and other infectious diseases
JP3055796B2 (ja) * 1990-11-19 2000-06-26 善蔵 田村 殺菌消毒剤組成物
US5198217A (en) 1991-09-24 1993-03-30 Choice Pharmaceuticals Topical demulcent for viral and inflammatory diseases of the skin
US6350784B1 (en) 1996-02-12 2002-02-26 Meryl J. Squires Antimicrobial prevention and treatment of human immunedeficiency virus and other infectious diseases
US5229423A (en) 1992-03-06 1993-07-20 Albert Einstein College Of Medicine Of Yeshiva University Use of butylurea as a contraceptive agent
AU5541594A (en) 1992-10-21 1994-05-09 Gynetech Laboratories, Inc. Vaginal sponge delivery system
FR2700698A1 (fr) 1992-11-09 1994-07-29 Mercurochrome Lab Unité de distribution de fluides particulièrement sensibles à la lumière, et/ou à la contamination bactérienne.
US5370876A (en) 1993-01-08 1994-12-06 Microbarriers Antimicrobial protective skin composition and method for protecting skin from body fluids
US5767163A (en) 1994-02-22 1998-06-16 Kundsin Leduc Lenmark Inc. Lubricating and/or germicidal composition
US5492932A (en) * 1994-02-22 1996-02-20 Kundsin Leduc Lenmark, Inc. Lubrication germicidal composition
US5661170A (en) 1994-03-21 1997-08-26 Woodward Laboratories, Inc. Antimicrobial compositions and methods for using the same
US5540934A (en) * 1994-06-22 1996-07-30 Touitou; Elka Compositions for applying active substances to or through the skin
JPH08164191A (ja) * 1994-12-13 1996-06-25 Kankyo Planning:Kk 消毒・除菌用ウエットティッシュ
JPH08217694A (ja) * 1995-02-09 1996-08-27 Pola Chem Ind Inc 抗掻痒皮膚外用剤
CA2143136A1 (en) 1995-02-22 1996-08-23 Chris Morris Rub on topical anesthetic
US5631245A (en) 1995-06-06 1997-05-20 Biodynamics Pharmaceuticals, Inc. Method for medicating the inflammatory controlling system and adverse inflammatory reactions and for making compounds for treating the pathology of adverse inflammatory reactions
US5906814A (en) 1995-12-07 1999-05-25 The Andrew Jergens Company Topical film-forming compositions
US5704906A (en) 1996-02-26 1998-01-06 Fox; Richard L. Method of using a topical anesthetic-cleaning solution and applicator
US5678273A (en) 1996-03-20 1997-10-21 Porcelli; V. Lorenzo Disposable oral hygiene applicator
US5952392A (en) 1996-09-17 1999-09-14 Avanir Pharmaceuticals Long-chain alcohols, alkanes, fatty acids and amides in the treatment of burns and viral inhibition
US5709866A (en) 1996-12-05 1998-01-20 Sage Products, Inc. Dual bag mouth care package
US5948822A (en) 1996-12-17 1999-09-07 Lidak Pharmaceuticals Treatment of hyperproliferative skin disorders with C18 to C26 alphatic alcohols
JPH10324624A (ja) * 1997-05-23 1998-12-08 Kao Corp 殺菌消毒剤組成物
DE69840524D1 (de) 1997-08-13 2009-03-19 Uab Research Foundation Impfung durch topische verwendung genetischer vektoren
GB9718791D0 (en) * 1997-09-05 1997-11-12 Glaxo Group Ltd Medicaments
EP1023899A1 (en) * 1997-09-26 2000-08-02 Wakamoto Pharmaceutical Co., Ltd. Aqueous preparation containing antiviral agent having purine or pyrimidine skeleton
US6211243B1 (en) * 1999-09-22 2001-04-03 B. Ron Johnson Methods for treating cold sores with anti-infective compositions

Also Published As

Publication number Publication date
EP1404174B1 (en) 2010-12-15
GB0207537D0 (en) 2002-05-08
GB2370774A (en) 2002-07-10
BR0014205A (pt) 2002-05-21
MXPA02002975A (es) 2002-10-23
US6420431B1 (en) 2002-07-16
EP1214064B1 (en) 2010-12-22
WO2001021170A1 (en) 2001-03-29
EP1404174A4 (en) 2006-04-12
US6211243B1 (en) 2001-04-03
CA2383293A1 (en) 2001-03-29
WO2001021171A1 (en) 2001-03-29
AU771816B2 (en) 2004-04-01
DE60045418D1 (de) 2011-02-03
GB0207539D0 (en) 2002-05-08
JP2003509164A (ja) 2003-03-11
ATE492268T1 (de) 2011-01-15
WO2001020981A3 (en) 2004-02-19
MXPA02002974A (es) 2002-10-23
AU777656B2 (en) 2004-10-28
AU7610800A (en) 2001-04-24
DE10085007T1 (de) 2002-10-10
US6423750B1 (en) 2002-07-23
BR0014209A (pt) 2002-05-21
CA2383293C (en) 2010-11-02
GB2370773A (en) 2002-07-10
JP5041643B2 (ja) 2012-10-03
JP5215514B2 (ja) 2013-06-19
WO2001020981A2 (en) 2001-03-29
ATE491436T1 (de) 2011-01-15
EP1214064A1 (en) 2002-06-19
JP2003529548A (ja) 2003-10-07
US6410599B1 (en) 2002-06-25
US6414032B1 (en) 2002-07-02
CA2384829A1 (en) 2001-03-29
AU7612400A (en) 2001-04-24
GB2370774B (en) 2004-12-08
EP1404174A2 (en) 2004-04-07
BR0014205B1 (pt) 2014-09-30
PE20010709A1 (es) 2001-07-12
AU7603000A (en) 2001-04-24
GB2370773B (en) 2004-08-04
DE60045394D1 (de) 2011-01-27
EP1214064A4 (en) 2006-01-18

Similar Documents

Publication Publication Date Title
AR025763A1 (es) Metodos y sistemas para el tratamiento del tejido enfermo con composiciones antiinfecciosas
DE60027463D1 (de) Pharmazeutische zusammensetzungen enthaltend resveratrol und verwendungen davon
DK1689724T3 (da) Quinazolinonforbindelser som anticancermidler
BRPI0406905A (pt) Espuma de fosfato de clindamicina
HN2004000232A (es) " derivados de pirrolo(3,4-c) pirazol activos como inhibidores de quinasa, proceso para su preparacion y composiciones farmaceuticas que los comprenden."
BRPI0510684A (pt) composições para adiministração tópica ou transdérmica de agente anticolinérgico ou antiespasmódico e uso dos respectivos compostos
MX2024000828A (es) Formulaciones de parasiticida de isoxazolina y metodos para el tratamiento de la blefaritis.
BR0311460A (pt) Composição farmacêutica de liberação modificada, uso de uma formulação, e, método para tratar um distúrbio cardiovascular em um paciente
WO2018102687A3 (en) Combination therapy for treating cancer
WO2017091767A3 (en) Drug formulations for cancer treatment
MX2021016055A (es) Formulaciones y métodos de parasiticidas de isoxazolina para el tratamiento de la blefaritis.
ES2143467T3 (es) Agente terapeutico para el tratamiento de las heridas.
BRPI0411702A (pt) uso de ácido hialurÈnico para preparar composições para o tratamento de aftas da cavidade oral
DK1276482T3 (da) Kombinationskemoterapi
MX382949B (es) Formulaciones tópicas de detomidina.
DK1194109T3 (da) Topiske formuleringer omfattende hud-gennemtrængningsmidler samt anvendelse deraf
DE60207606D1 (de) Artikel zur wundbehandlung
PA8471801A1 (es) Derivados de higromicina a
WO2019142124A4 (en) Pharmaceutical compositions for treatment of vitiligo
AR010432A1 (es) Composiciones farmaceuticas que contienen acido ricinoleico y su uso para la terapia antiinflamatoria y analgesica
ES2059204T3 (es) Derivados del acido hidroxamico inhibidores de lipoxigenasa.
HUP0204180A2 (hu) Külsőleges készítmény és alkalmazása allergiás dermatitisz kezelésére
AR005730A1 (es) Forma de fanciclovir, procedimiento para prepararla, composiciones farmaceuticas que la contienen y metodo para el tratamiento o profilaxis deinfecciones virales y el uso de dicha forma -fanciclovir monoidrato.
WO2000074667A3 (en) Compositions active in telomere damage comprising a taxane and telomerase inhibitor
WO2023275620A3 (en) Use of isoquinoline-1,5-diamines for wound healing

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed, e.g., due to non-payment of fee